The Impact of rs767455 and rs1061622 Polymorphisms on Treatment Outcomes in Iraqi Ankylosing Spondylitis Patients Taking Etanercept

The Impact of rs767455 and rs1061622 Polymorphisms ‎on ‎Treatment Outcomes in Iraqi Ankylosing Spondylitis ‎Patients Taking ‎Etanercept

Evaluation of Drug Effects on IL-17 and TNF levels in Patients with Rheumatoid Arthritis

AZATHIOPRINE AND BIOLOGICAL TREATMENT GENETIC ASSOCIATION WITH CLINICAL RESPONSE AND TOXICITY IN INFLAMMATORY BOWEL DISEASE PATIENTS

Molecular expression and single nucleotide polymorphisms of the IL17A gene among etanercept-treated rheumatoid arthritis patients

Serum Level of Interleukin-33 in Ankylosing Spondylitis Patients and Its Relation with Disease Parameters

Interleukin-22 and Tumor Necrosis Factor Receptor Associated Factor 1 (TRAF1) in Patients with Rheumatoid Arthritis and Systemic Lupus Erythematosus: Correlation with Disease Activity

Immunogenic Study for CX3CR1 Molecule in Rheumatoid Arthritis Patients

Association of Interleukin-12B Polymorphism and Serum Level of Interleukin-12 in a Sample of Iraqi Patients with Rheumatoid Arthritis

Study of Toll -like Receptor 4 and Colony Stimulating Factor 2 Gene Expression for Early Recognition of Axial Spondyloarthritis Changes in Psoriatic cases.